Jun 27, 2024 | In the News
Modern Space Allows Room for Growth, Collaboration and Wellness BOSTON, June 27, 2024 — Elucid, a pioneering medical technology company providing physicians with imaging analysis software based on ground truth histology to support treatment of cardiovascular...
Nov 9, 2023 | Press Releases
Investment will drive commercialization and expansion of AI-powered non-invasive diagnostic tools to help evaluate cardiovascular risk BOSTON, Nov. 9, 2023 – Elucid, a leading medical technology company providing physicians with AI-powered imaging analysis software to...
Apr 25, 2023 | Press Releases
BOSTON, April 25, 2023 – Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, today announced that it has named Scott Huennekens executive chairman of its board of...
Mar 28, 2023 | Press Releases
BOSTON, March 28, 2023 – Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, has hired Andrew Miller as its chief technology officer (CTO). In this role, Andrew will lead...
Jan 26, 2023 | Press Releases
BOSTON, January 26, 2023 – Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging analysis software to characterize cardiovascular disease, today announced the addition of Scott Burger as chief commercial officer. His...
